Neurological Disorders Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
LATEST RECOMMENDATION
Marco Rovaris, IRCCS Santa Maria Nascente, Italy. F1000 Neurological Disorders
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
6 Recommendations, most recent by
Shimon Amir and Michael Verwey, Concordia University, Canada. F1000 Physiology
- Good for Teaching
- New Finding
- Technical Advance
Past 7 Days
28
New Recommendations
11,147 total
20
New Articles Recommended
6,600 total
Past 30 Days
-
7Articles Classified As Controversial682 total
-
13Articles Classified As Novel Drug Target215 total
-
8Articles Classified As Review / Commentary506 total
-
22Articles Classified As Confirmation2,453 total
-
13Articles Classified As Technical Advance789 total
-
66Articles Classified As New Finding6,213 total
-
28Articles Classified As Interesting Hypothesis1,483 total
-
18Articles Classified As Good for Teaching227 total
-
39Articles Classified As Clinical Trial1,995 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

